Abstract
Recent studies indicate that impairments in two cognitive domains characterize the cognitive abnormalities that appear earliest in the course of Alzheimer disease (AD). These cognitive domains pertain to memory and executive function ability; in particular, memory test scores reflecting the difference between immediate and delayed recall and tasks that assess cognitive flexibility (e.g., set-shifting). Preliminary data indicate that tasks of this nature, along with specific genetic information (i.e., APOE-4 status), are important in identifying which individuals with recent cognitive changes (considered to have “questionable” disease) will progress to the point where they meet criteria for AD over time. When this cognitive and genetic information is combined with neuroimaging measures targeted at the brain regions demonstrating pathology early in AD, it may serve as specific and accurate prognostic markers of AD.
Keywords
CognitionCognitive flexibilityRecallEpisodic memoryDiseaseNeuroimagingPsychologyCognitive psychologyAlzheimer's diseaseApolipoprotein ESet (abstract data type)NeuroscienceMedicineComputer sciencePathology
Affiliated Institutions
Related Publications
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Recently, we demonstrated a significant increase of an oxidized nucleoside derived from RNA, 8-hydroxyguanosine (8OHG), and an oxidized amino acid, nitrotyrosine in vulnerable n...
Memory function in normal aging
We evaluated memory function in a group of 161 community-dwelling, cognitively normal individuals aged 62 to 100 years recruited as part of the Mayo Clinic Alzheimer's Disease P...
A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment
Given the relationship between the presence of ApoE epsilon 4 and Alzheimer's disease (AD), were studied whether knowledge of epsilon 4 status would predict which memory-impaire...
Neuropsychological changes in asymptomatic persons with Alzheimer disease neuropathology
Clinically normal individuals who come to autopsy with AD neuropathologic change exhibit subtle evidence of declining cognitive trajectories for attention/working memory.
Alzheimer disease
Alzheimer disease (AD) is biologically defined by the presence of β-amyloid-containing plaques and tau-containing neurofibrillary tangles. AD is a genetic and sporadic neu...
Publication Info
- Year
- 1996
- Type
- review
- Volume
- 93
- Issue
- 24
- Pages
- 13547-13551
- Citations
- 243
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
243
OpenAlex
Cite This
Marilyn S. Albert
(1996).
Cognitive and neurobiologic markers of early Alzheimer disease.
Proceedings of the National Academy of Sciences
, 93
(24)
, 13547-13551.
https://doi.org/10.1073/pnas.93.24.13547
Identifiers
- DOI
- 10.1073/pnas.93.24.13547